Therapeutic application of chimeric RNA/DNA oligonucleotide based gene therapy

Bibliography

• KREN BT, BANDYOPADHYAY P, STEER CJ: In vivo site-directed mutagenesis of the Factor IX gene by chimeric RNA/DNA oligonucleotides. Nature Med. (1998) 4:285–290.
   PubMed Web of Science ®Google Scholar
• •The first chimera-mediated gene conversion in vivo.
   Google Scholar
• KREN BT, PARASHAR B, BANDYOPADHYAY P, CHOWDHURY NR, CHOWDHURY JR, STEER CJ: Correc-tion of the UDP-glucuronosyltransferase gene defect in the Gunn rat model of Crigler-Najjar syndrome Type I with a chimeric oligonucleotide. Proc. Natl. Acad. Sci. USA (1999) 96:10349–10354.
   PubMed Web of Science ®Google Scholar
• •The first group applying chimera technique to correct the mutation causing inborn errors of metabolism with restora-tion of a clinically significant level of enzymatic activity in vivo.
   Google Scholar
• ALEXEEV V, IGOUCHEVA 0, DOMASHENKO A, COTSARELIS G, YOON K: localized in vivo genotypic and phenotypic correction of the albino mutation in skin by RNA-DNA oligonucleotide. Nature Biotechnol. (2000) 18:43–47.
   PubMed Web of Science ®Google Scholar
• •The first group applying chimera technique to the dermato-logical problems in vivo.
   Google Scholar
• BARTLETT RJ, STOCKINGER S, DENTS MM, METCALF-BOGAN J, KORNEGAY JN: In vivo targeted repair of a point mutation in the canine dystrophin gene by a chimeric RNA/DNA o ligo n ucleo tide. Nature Biotechnol. (2000) 18:615–622.
   PubMed Web of Science ®Google Scholar
• RANDO TA, DISATNIK MH, ZHOU LZ: Rescue of dystro-phin expression in mdx mouse muscle by RNA/DNA oligonucleotides. Proc. Natl. Acad. Sci. USA (2000) 97:5363–5368.
   PubMed Web of Science ®Google Scholar
• LAI L, CHAU B, KAHN R, LIEN, YH: Gene targeting in the kidney of carbonic anhydrase II deficient mice by chimeric RNA/DNA oligonucleotides. J. Am. Soc. Nephrol. (1999) 10:447A.
   Google Scholar
• LAI L, LUO M, LIEN YH: Correction of a point mutation in a-galactosidase gene by chimeric RNA/DNA oligonucleotides in cultured peripheral lymphocytes and lymphoblasts from a patient with Fabry disease. J. Am. Soc. Nephrol. (2000) 11:409A.
   Google Scholar
• TAN Y, LI S, PITT BR, HUANG L: The inhibitory role ofCpG immunostimulatory motifs in cationic lipid vector-mediated transgene expression in vivo. Human Gene Ther. (1999) 10:2153–2161.
   PubMed Web of Science ®Google Scholar
• KMIEC EB: Targeted gene repair. Gene Ther. (1999) 6:1–3.
   PubMed Web of Science ®Google Scholar
• KOTANI H, KMIEC EB: A role for RNA synthesis inhomologous pairing events. Mot. Cell Biol. (1994) 14:6097–6106.
   Web of Science ®Google Scholar
• •A pioneer discovery leading to the design of chimera.
   Google Scholar
• KOTANI H, KMIEC EB: Transcription activates RecA-promoted homologous pairing of nucleosomal DNA. Mot. Cell Biol. (1994) 14:1949–1955.
   Web of Science ®Google Scholar
• •A pioneer discovery leading to the design of chimera.
   Google Scholar
• KOTANI H, GERMANN MW, ANDRUS A, VINAYAK R, MULLAH B, KMIEC EB: RNA facilitates RecA-mediated DNA pairing and strand transfer between molecules bearing limited regions of homology. Mol. Gen. Genet. (1996) 250:626–634.
   PubMedGoogle Scholar
• COLE-STRAUSS A, GAMPER H, HOLLOMAN WK, MUNOZM, CHENG N, KMIEC EB: Targeted gene repair directed by the chimeric RNA/DNA oligonucleotide in a mammalian cell-free extract. Nucleic Acid Res. (1999) 27:1323–1330.
   PubMed Web of Science ®Google Scholar
• GAMPER HB JR, COLE-STRAUSS A, METZ R, PAREKH H,KUMAR R, KMIEC EB: A plausible mechanism for gene correction by chimeric oligonucleotides. Biochemistry (2000) 39:5808–5816.
   PubMed Web of Science ®Google Scholar
• GAMPER HB JR, PAREKH H, RICE MC, BRUNER M, YOUKEY H, KMIEC EB: The DNA strand of chimeric RNA/DNA oligonucleotides can direct gene repair/conversion activity in mammalian and plant cell-free extracts. Nucleic Acid Res. (2000) 28:4332–4339.
   PubMed Web of Science ®Google Scholar
• COLE-STRAUSS A, YOON K, XIANG Y et al.: Correction ofthe mutation responsible for sickle cell anemia by an RNA-DNA Oligonucleotide. Science (1 9 9 6) 273:1386-1389.
   Google Scholar
• •The first chimera-mediated gene conversion of mammalian genome in mammalian cells.
   Google Scholar
• KREN BT, COLE-STRAUSS A, KMIEC EB, STEER CJ:Targeted nucleotide exchange in the alkaline phosphatase gene of HuH-7 cells mediated by a chimeric RNA/DNA oligonucleotide. Hepatology (1997) 25:1462–1468.
   PubMed Web of Science ®Google Scholar
• BEETHAM PR, KIPP PB, SAWYCKY XL, ARNTZEN CJ, MAYGD: A tool for functional plant genomics: chimeric RNA/DNA oligonucleotides cause in vivo gene-specific mutations. Proc. Natl. Acad. Sci. USA (1999)96:8774–8778.
   PubMed Web of Science ®Google Scholar
• ZHU T, PETERSON DJ, TAGLIANI L, ST CLAIR G,BASZCZYNSKI CL, BOWEN B: Targeted manipulation of maize genes in vivo using chimeric RNA/DNA oligonu-cleotides. Proc. Natl. Acad. Sci. USA (1999) 96:8768–8773.
   PubMed Web of Science ®Google Scholar
• LAI L, CHAN D, ERICKSON RP, HSU SJ, LIEN YH: Correc-tion of renal tubular acidosis in carbonic anhydrase II deficient mice with gene therapy. J. an. Invest. (1998) 1 01:1320–1325.
   Google Scholar
• LUO M, LIEN YH, LAI L: Mutation analysis for non-target gene after gene targeting by chimeric RNA/DNA oligonucleotides. Mol. Ther. (2000) 1:S228.
   Google Scholar
• ALEXEEV V, YOON K: Stable and inheritable changes in genotype and phenotype of albino melanocytes induced by an RNA-DNA oligonucleotide. Nature Biotechnol. (1998) 16:1343–1346.
   PubMed Web of Science ®Google Scholar
• STRAUSS M: The site-specific correction of genetic disorders. Nature Med. (1998) 4:274–275.
   PubMed Web of Science ®Google Scholar
• WENTVVORTH P, JR.: Recent developments and applica-tions of liquid-phase strategies in organic synthesis. Trends Biotechnol. (1999) 17:448–452.
   Google Scholar